Company intelligence / Profile preview

Lucine Biotechnology

Henderson, Nevada, USAlucinecenter.com ↗

Ownership: Private
Development stage: Other

Overview

Lucine Biotechnology aimed to develop affordable salivary diagnostics for women’s hormone-related OB/GYN conditions by leveraging a digital platform to collect real-world symptom and medication data from users. The company sought to standardize reference ranges for hormones using large-scale user-generated datasets but had not yet launched commercial products as of the last public update in 2012–2013.[5]

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Diagnostic testNon-pharmacological therapy
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Lucine Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lucine Biotechnology.

Explore the full profile